meloxicam 15 MG Oral Tablet
1 INDICATIONS AND USAGE Meloxicam Tablets are non-steroidal anti-inflammatory drug indicated for: Osteoarthritis (OA) ( 1.1 ) Rheumatoid Arthritis (RA) ( 1.2 ) Juvenile Rheumatoid Arthritis (JRA) in patients who weigh ≥ 60 kg ( 1.3 ) 1.1 Osteoarthritis (OA) Meloxicam tablets are indicated for relief of the signs and symptoms of Osteoarthritis [ see Clinical Studies ( 14.1 ) ] . 1.2 Rheumatoid Arthritis (RA) Meloxicam tablets are indicated for relief of the signs and symptoms of Rheumatoid Arthritis [see Clinical Studies ( 14.1 ) ]. 1.3 Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course Meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis in patients who weigh ≥ 60 kg [see Dosage and Administration ( 2.4 ) and Clinical Studies ( 14.2 )].
Zydus Pharmaceuticals (USA) Inc.
ROUND YELLOW ZC 26
ZC 26 ROUND YELLOW
Related Pills
meloxicam 7.5 MG Oral Tablet
Zydus Pharmaceuticals (USA) Inc.
meloxicam tablet
zydus pharmaceuticals (usa) inc.
meloxicam 15 mg
American Health Packaging
meloxicam 15 mg
American Health Packaging
meloxicam 15 mg
American Health Packaging
meloxicam 15 mg
American Health Packaging
meloxicam 15 mg
American Health Packaging
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
MELOXICAM Tablets USP, 7.5 mg are yellow, round-shaped, flat beveled edge, uncoated tablets debossed with 'ZC' and '25' on one side and plain on other side and are supplied as follows: NDC 68382-050-16 in bottles of 90 tablets with child-resistant closure NDC 68382-050-01 in bottles of 100 tablets NDC 68382-050-05 in bottles of 500 tablets NDC 68382-050-40 in bottles of 5000 tablets NDC 68382-050-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets
MELOXICAM Tablets USP, 15 mg are yellow, round-shaped, flat beveled edge, uncoated tablet debossed with 'ZC' and '26' on one side and plain on other side and are supplied as follows: NDC 68382-051-16 in bottles of 90 tablets with child-resistant closure NDC 68382-051-01 in bottles of 100 tablets NDC 68382-051-05 in bottles of 500 tablets NDC 68382-051-40 in bottles of 5000 tablets NDC 68382-051-77 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets Storage Store at 20° C to 25° C (68° F to 77° F) [see USP Controlled Room Temperature]. Keep
MELOXICAM tablets in a dry place. Dispense tablets in a tight container. Keep this and all medications out of the reach of children.
More pills like ROUND ZC 26